Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study

HPV and Gynecologic Cancer

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Lancet Oncol.

Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, Meijer CJLM, Quint WGV, Snijders PJF, Massuger LFAG, van Kemenade FJ, Berkhof J

doi: 10.1016/S1470-

HPV and Gynecologic CancerReproductive Health

Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study

Am J Obstet Gynecol.

Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC

doi: 10.1016/j.ajog.2017.02.002.

HPV and Gynecologic Cancer

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Lancet

Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P

doi: 10.1016/S0140-6736(21)02178-4

HPV and Gynecologic Cancer

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Am J Obstet Gynecol.

Loopik DL, Koenjer LM, Siebers AG, Melchers WJG, Bekkers RLM

doi: 10.1016/j.ajog.2020.08.026.

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

Further Publications UrologyFurther Publications Gynecology

A prospective study of treatments for cervical intraepithelial neoplasia and fecundability

Am J Obstet Gynecol.

Wise LA, Willis SK, Perkins RB, Wesselink AK, Klann A, Crowe HM, Hahn KA, Mikkelsen EM, Hatch EE

doi: 10.1016/j.ajog.2019.12.017.

HPV and Gynecologic Cancer

Incomplete Excision of Cervical Intraepithelial Neoplasia as a Predictor of the Risk of Recurrent Disease - a 16 Year Follow-Up Study

Am J Obstet Gynecol.

Alder S, Megyessi D, Sundström K, Östensson E, Mints M, Belkić K, Arbyn M, Andersson S

doi: 10.1016/j.ajog.2019.08.042.

HPV and Gynecologic Cancer

Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women

Am J Obstet Gynecol.

Dempster-Rivett K, Innes CR, Simcock BJ, Harker D, Williman JA, Van Der Griend RA, Whitehead M, Hibma M, Lawton BA, Fitzgerald P, Dudley NM, Petrich S, Faherty J, Bergzoll C, Eva L, Sadler L, Pather S, Wrede CD, Sykes PH

doi: 10.1016/j.ajog.2020.02.029.

HPV and Gynecologic Cancer

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

Lancet HIV.

Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P; ART and HPV Review Group

doi: 10.1016/

Related content

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Benefit and burden in the Dutch cytology-based versus high-risk human papillomavirus-based cervical cancer screening program

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

A prospective study of treatments for cervical intraepithelial neoplasia and fecundability

Incomplete Excision of Cervical Intraepithelial Neoplasia as a Predictor of the Risk of Recurrent Disease - a 16 Year Follow-Up Study

Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis